Meeting
2019 Gastrointestinal Cancers Symposium
FGFR2-altered gastroesophageal adenocarcinomas (GEA) are a rare clinicopathologic entity with a distinct genomic landscape.
Authors
Samuel Jacob Klempner
The Angeles Clinic and Research Institute, Los Angeles, CA
Samuel Jacob Klempner , Russell Madison , Jeffrey S. Ross , Vincent A. Miller , Siraj Mahamed Ali , Alexa Betzig Schrock , Jeeyun Lee , Seung Tae Kim , Joseph Chao
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Translational Research
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 72)
DOI
10.1200/JCO.2019.37.4_suppl.72
Abstract #
72
Poster Bd #
H2
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA-based genomic landscape of early-onset pancreatic cancer.
First Author: Reagan Barnett
First Author: Russell Madison
Poster
2018 ASCO Annual Meeting
Real-time circulating tumor DNA profiling of advanced cholangiocarcinoma (CCA).
First Author: Kabir Mody
First Author: Jeffrey S. Ross